Yeong Min Park

Title: Yeong Min Park: Innovator in Antibacterial and Hepatitis B Treatments

Introduction

Yeong Min Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the fields of antibacterial treatments and hepatitis B therapies. With a total of 5 patents, his work showcases innovative approaches to combating serious health issues.

Latest Patents

Yeong Min Park's latest patents include a polypeptide with antibacterial activity and a composition for preventing or treating sepsis. This invention provides a peptide that not only suppresses bacterial growth but also removes endotoxins derived from bacteria. The therapeutic effect on sepsis is particularly noteworthy, as the peptide exhibits selective antibacterial activity against both Gram-positive and Gram-negative bacteria. Additionally, it demonstrates excellent resistance against proteolytic enzymes, making it highly stable and suitable for various applications, including pharmaceutical and cosmetic compositions. Another significant patent involves a pharmaceutical composition for preventing or treating hepatitis B, which utilizes oligonucleotides to form a G-quadruplex with HBV, effectively reducing cccDNA and aiding in treatment.

Career Highlights

Throughout his career, Yeong Min Park has worked with notable institutions, including the Konkuk University Glocal Industry-Academic Collaboration Foundation and Am Sciences Inc. His research has led to advancements in medical treatments that address critical health challenges.

Collaborations

Some of his coworkers include In Duk Jung and Jung Hee Park, who have contributed to his innovative projects and research endeavors.

Conclusion

Yeong Min Park's contributions to antibacterial and hepatitis B treatments highlight his role as a leading inventor in the medical field. His innovative patents and collaborations continue to pave the way for advancements in healthcare solutions.